Baylor Health Care System/Sammons Cancer Center Dept. of Sammons Cancer (2) is a clinical research site located in Dallas, Texas, United States 75246.
Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.
Baylor Health Care System/Sammons Cancer Center Dept. of Sammons Cancer (2) has participated in 1 clinical trials.
Therapeutic areas: CML, Philadelphia Chromosome Positive (Ph+), Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib Trough Levels.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Baylor Health Care System/Sammons Cancer Center Dept. of Sammons Cancer (2) has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Baylor Health Care System/Sammons Cancer Center Dept. of Sammons Cancer (2) has 1 clinical trials on record. Their work covers CML, Philadelphia Chromosome Positive (Ph+), Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib Trough Levels.
Baylor Health Care System/Sammons Cancer Center Dept. of Sammons Cancer (2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.